Back to Search Start Over

P768: GUADECITABINE (SGI‐110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY.

Authors :
Garcia‐Manero, G.
Bart, S.
McCloskey, J. K.
Fenaux, P.
Selleslag, D.
Reda, G.
Valcárcel, D.
Santini, V.
Mayer, J.
Xicoy, B.
Yamaguchi, H.
Lübbert, M.
Miyazaki, Y.
Keer, H.
Hao, Y.
Azab, M.
Döhner, H.
Source :
HemaSphere; 2022 Supplement 3, Vol. 6, p663-664, 2p
Publication Year :
2022

Details

Language :
English
ISSN :
25729241
Volume :
6
Database :
Complementary Index
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
175292445
Full Text :
https://doi.org/10.1097/01.HS9.0000845956.26644.d0
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details